Mary Anne Papalia

Summary

Affiliation: Monash University
Country: Australia

Publications

  1. ncbi request reprint Clinical evaluation of women presenting with low libido and determination of whether androgen therapy might be appropriate
    Mary Anne Papalia
    Women s Health Program, Department of Medicine, Monash University, Alfred Hospital, Commercial Road, Prahran, Victoria 3181, Australia
    Semin Reprod Med 24:86-96. 2006
  2. ncbi request reprint Testosterone aromatization and cognition in women: a randomized, placebo-controlled trial
    Sonal Shah
    NH and MRC Centre of Clinical Research Excellence in the Women s Health Program, Department of Medicine, Central and Eastern Clinical School, Monash University, Alfred Hospital, Prahran, Victoria, Australia
    Menopause 13:600-8. 2006
  3. ncbi request reprint Effects of aromatase inhibition on sexual function and well-being in postmenopausal women treated with testosterone: a randomized, placebo-controlled trial
    Susan R Davis
    Women s Health Program, Department of Medicine, Central and Eastern Clinical School, Monash University, Alfred Hospital, Prahran, Victoria, Australia
    Menopause 13:37-45. 2006
  4. ncbi request reprint Safety and efficacy of a testosterone metered-dose transdermal spray for treating decreased sexual satisfaction in premenopausal women: a randomized trial
    Susan Davis
    Women s Health Program, Department of Medicine, Monash University, Alfred Hospital, Prahran, Victoria, Australia
    Ann Intern Med 148:569-77. 2008
  5. doi request reprint Effects of the route of estrogen administration on insulinlike growth factor-I, IGF binding protein-3, and insulin resistance in healthy postmenopausal women: results from a randomized, controlled study
    Susan R Davis
    Women s Health Program, Department of Medicine, Monash Medical School, Alfred Hospital, Prahran, Victoria, Australia
    Menopause 15:1065-9. 2008
  6. ncbi request reprint Endogenous androgen levels and cardiovascular risk profile in women across the adult life span
    Robin J Bell
    Women s Health Program, Department of Medicine, Central and Eastern Clinical School, Monash University, Clayton, Victoria, Australia
    Menopause 14:630-8. 2007
  7. doi request reprint Methodology and challenges to recruitment to a randomized, double-blind, placebo-controlled trial of oral DHEA in postmenopausal women
    Mary Panjari
    NH and MRC Centre of Clinical Research Excellence in the Women s Health Program, Department of Medicine, Central and Eastern Clinical School, Monash University, Alfred Hospital, Prahran, Victoria, Australia
    J Womens Health (Larchmt) 17:1559-65. 2008
  8. ncbi request reprint What is the rationale for androgen therapy for women?
    Mary Anne Papalia
    The Jean Hailes Foundation Research Unit, Clayton, Victoria, Australia
    Treat Endocrinol 2:77-84. 2003
  9. ncbi request reprint A clinical update on female androgen insufficiency--testosterone testing and treatment in women presenting with low sexual desire
    Henry G Burger
    The Jean Hailes Foundation, Clayton, Australia
    Sex Health 3:73-8. 2006

Detail Information

Publications9

  1. ncbi request reprint Clinical evaluation of women presenting with low libido and determination of whether androgen therapy might be appropriate
    Mary Anne Papalia
    Women s Health Program, Department of Medicine, Monash University, Alfred Hospital, Commercial Road, Prahran, Victoria 3181, Australia
    Semin Reprod Med 24:86-96. 2006
    ..This review outlines the various causes of FSD, clinical and biochemical investigations required to diagnose androgen deficiency, and options for treatment of the woman found to have androgen deficiency as a cause of FSD...
  2. ncbi request reprint Testosterone aromatization and cognition in women: a randomized, placebo-controlled trial
    Sonal Shah
    NH and MRC Centre of Clinical Research Excellence in the Women s Health Program, Department of Medicine, Central and Eastern Clinical School, Monash University, Alfred Hospital, Prahran, Victoria, Australia
    Menopause 13:600-8. 2006
    ..To explore whether inhibition of the conversion of testosterone to estradiol modifies the effects of testosterone on cognition in 61 healthy, estrogen-treated postmenopausal women...
  3. ncbi request reprint Effects of aromatase inhibition on sexual function and well-being in postmenopausal women treated with testosterone: a randomized, placebo-controlled trial
    Susan R Davis
    Women s Health Program, Department of Medicine, Central and Eastern Clinical School, Monash University, Alfred Hospital, Prahran, Victoria, Australia
    Menopause 13:37-45. 2006
    ..Therefore, the authors investigated the effects of aromatase enzyme inhibition on sexual function, well-being, and mood in estrogen- and T-replete postmenopausal women in a double-blind, randomized, placebo-controlled study...
  4. ncbi request reprint Safety and efficacy of a testosterone metered-dose transdermal spray for treating decreased sexual satisfaction in premenopausal women: a randomized trial
    Susan Davis
    Women s Health Program, Department of Medicine, Monash University, Alfred Hospital, Prahran, Victoria, Australia
    Ann Intern Med 148:569-77. 2008
    ..It is not known whether premenopausal women who report low sexual satisfaction and have low circulating testosterone levels will benefit from testosterone therapy...
  5. doi request reprint Effects of the route of estrogen administration on insulinlike growth factor-I, IGF binding protein-3, and insulin resistance in healthy postmenopausal women: results from a randomized, controlled study
    Susan R Davis
    Women s Health Program, Department of Medicine, Monash Medical School, Alfred Hospital, Prahran, Victoria, Australia
    Menopause 15:1065-9. 2008
    ..The aim of the study was to investigate the effects of intranasal E2 with norethisterone (E2/NET) versus oral E2/NET acetate on IGF-I, IGF binding protein 3, and insulin resistance in postmenopausal women...
  6. ncbi request reprint Endogenous androgen levels and cardiovascular risk profile in women across the adult life span
    Robin J Bell
    Women s Health Program, Department of Medicine, Central and Eastern Clinical School, Monash University, Clayton, Victoria, Australia
    Menopause 14:630-8. 2007
    ....
  7. doi request reprint Methodology and challenges to recruitment to a randomized, double-blind, placebo-controlled trial of oral DHEA in postmenopausal women
    Mary Panjari
    NH and MRC Centre of Clinical Research Excellence in the Women s Health Program, Department of Medicine, Central and Eastern Clinical School, Monash University, Alfred Hospital, Prahran, Victoria, Australia
    J Womens Health (Larchmt) 17:1559-65. 2008
    ..To report on the issues encountered in the recruitment of healthy naturally menopausal women in the community to a randomized placebo-controlled trial of dehydroepiandrosterone (DHEA) therapy for treatment of loss of sexual desire...
  8. ncbi request reprint What is the rationale for androgen therapy for women?
    Mary Anne Papalia
    The Jean Hailes Foundation Research Unit, Clayton, Victoria, Australia
    Treat Endocrinol 2:77-84. 2003
    ..However, clear guidelines regarding the diagnosis of androgen insufficiency, optimal therapeutic doses, and long-term safety remain lacking...
  9. ncbi request reprint A clinical update on female androgen insufficiency--testosterone testing and treatment in women presenting with low sexual desire
    Henry G Burger
    The Jean Hailes Foundation, Clayton, Australia
    Sex Health 3:73-8. 2006
    ..Currently, available methods include testosterone implants and testosterone creams, and transdermal patches and sprays are in development...